Cargando…
Gene Therapy Strategies for HIV/AIDS: Preclinical Modeling in Humanized Mice
In the absence of an effective vaccine and lack of a complete cure, gene therapy approaches to control HIV infection offer feasible alternatives. Due to the chronic nature of infection, a wide window of opportunity exists to gene modify the HIV susceptible cells that continuously arise from the bone...
Autores principales: | Bennett, Michael S., Akkina, Ramesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967164/ https://www.ncbi.nlm.nih.gov/pubmed/24351796 http://dx.doi.org/10.3390/v5123119 |
Ejemplares similares
-
Ultra-Sensitive HIV-1 Latency Viral Outgrowth Assays Using Humanized Mice
por: Schmitt, Kimberly, et al.
Publicado: (2018) -
Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy
por: Anderson, Joseph S, et al.
Publicado: (2006) -
Preclinical test of a lentivirus-mediated RNAi gene therapy against HIV-AIDS in the humanized mouse model
por: Centlivre, Mireille, et al.
Publicado: (2011) -
HIV-1 infection and CD4 T cell depletion in humanized Rag2-/-yc-/- mice
por: Berges, Bradford, et al.
Publicado: (2006) -
Human embryonic stem cell (hES) derived dendritic cells are functionally normal and are susceptible to HIV-1 infection
por: Bandi, Sriram, et al.
Publicado: (2008)